Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis (Q41541234)

2 October 2017

title

Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis (English)

1 reference

2 October 2017

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis (English)

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(82)80003-X

21 August 2023

0 references

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(82)80003-X

21 August 2023

author name string

Uchida A

1

1 reference

2 October 2017

Maida EM

2

1 reference

2 October 2017

Lenzhofer R

3

1 reference

2 October 2017

Micksche M

4

1 reference

2 October 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6175561

21 August 2023

publication date

1 February 1982

1 reference

full work available at URL

2 October 2017

https://api.elsevier.com/content/article/PII:S017129858280003X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(82)80003-X

https://api.elsevier.com/content/article/PII:S017129858280003X?httpAccept=text/plain

21 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(82)80003-X

21 August 2023

1 reference

2 October 2017

volume

160

1 reference

2 October 2017

issue

5

1 reference

2 October 2017

page(s)

392-402

1 reference

Measles antibody in serum of multiple sclerosis patients, their children, siblings and parents

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

A suppression of cellular immunity in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

The significance of the association between HLA and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Natural Cell-Mediated Immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Mechanisms of Activation of Human Natural Killer Cells Against Tumor and Virus-infected Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Plasmapheresis in multiple sclerosis: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Plasmapheresis in multiple sclerosis: preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Reduction of suppressor cells in cancer patients treated with OK-432 immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

In vitro augmentation of natural killing activity by OK-432

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Natural killer cells: characteristics and regulation of activity

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2882%2980003-X

7 January 2021

Inhibition of mitogen induced blast transformation by a multiple sclerosis serum factor

6

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(82)80003-X

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor

21 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0171-2985(82)80003-X

21 August 2023

Identifiers

0 references

1 reference